Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2022-11-28 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It includes detailed information on repurchases of shares, cancellations, and confirmations by the board of directors. The document references compliance with listing rules of the Stock Exchange of Hong Kong and provides specifics on share repurchase transactions. This type of filing is a formal announcement regarding share repurchases and capital changes, not a full financial report or earnings release. It fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares.
2022-11-28 English
TERMS OF REFERENCE OF THE AUDIT COMMITTEE
Governance Information Classification · 95% confidence The document is titled 'TERMS OF REFERENCE OF THE AUDIT COMMITTEE' for Transcenta Holding Limited. It details the purpose, composition, authority, responsibilities, and meeting procedures of the Audit Committee. The content focuses on governance, audit oversight, ESG duties, and committee operations rather than presenting financial statements or audit results. There is no indication that this is an audit report itself, nor is it an annual or interim report. It is a governance document related to the audit committee's role and responsibilities, which aligns with Governance Information filings. The document is substantive and not a brief announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the best fit is Governance Information (CGR).
2022-11-25 English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE
Remuneration Information Classification · 95% confidence The document is titled 'TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE' for Transcenta Holding Limited. It details the purpose, composition, authority, responsibilities, meetings, access, reporting procedures, and AGM attendance related to the Remuneration Committee. The content focuses on the committee's role in recommending and overseeing remuneration policies for directors and senior management, including incentive schemes and compensation. There are no financial statements, earnings data, or regulatory filings present. This document is a governance-related report detailing internal rules and committee responsibilities, specifically about remuneration. Therefore, it fits the category of Remuneration Information (DEF 14A).
2022-11-25 English
CONNECTED TRANSACTION IN RELATION TO CANCELLATION OF SHARE OPTIONS AND PROMISSORY NOTES
Capital/Financing Update Classification · 95% confidence The document is an announcement from Transcenta Holding Limited regarding a connected transaction related to the cancellation of share options and promissory notes. It details the terms of cancellation agreements, the amounts involved, the parties (including directors and employees), and the implications under the Hong Kong Stock Exchange Listing Rules. The document is an announcement of a corporate action involving share options and promissory notes, not a financial report, earnings release, or management discussion. It also involves directors and connected persons, but it is not a director's dealing report (which would focus on personal share transactions). The content fits best under Capital/Financing Update (CAP) because it concerns changes in capital structure through cancellation of shares and options and settlement of promissory notes. The document is lengthy and detailed, not a brief notice or a report publication announcement. Therefore, the classification is CAP with high confidence.
2022-11-25 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return related to changes in issued share capital and share buybacks for Transcenta Holding Limited, submitted to the Stock Exchange of Hong Kong. It details numerous repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules. The content is focused on share repurchase activities and changes in issued shares, not on financial results, management changes, or other report types. This matches the description of a Transaction in Own Shares filing, which reports company buybacks or sales of its own shares. The document is substantive and detailed, not a brief announcement or certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2022-11-18 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Transcenta Holding Limited. It details numerous repurchases of shares over a period, including dates, quantities, and prices. The document references compliance with listing rules of the Stock Exchange of Hong Kong and confirms that repurchases were made in accordance with these rules. There is no indication of this being a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure of share repurchase transactions and changes in issued share capital. This fits the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement of a report publication.
2022-11-17 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.